Bausch targets India-based firm over IBS drug generic
20-06-2023
Pharma unit could get green light to launch IBS generic
02-08-2022
Bausch settles $300m antitrust case over diabetes drug price hikes
13-09-2021
Patent litigation: a global perspective
11-05-2021
Sandoz fails in Enbrel patent challenge, but Fed Circuit split
02-07-2020
US judge dismisses attorney’s ‘opportunistic’ whistleblower suit
14-05-2020
Senju, Bausch settle eye drop litigation against Indian generics maker
09-01-2020
Bausch targets Sandoz over IBS generic
03-10-2019